Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension.

Autor: Felix, Nathane Santanna1,2 (AUTHOR), Mendonça, Lucas1,2 (AUTHOR), Braga, Cassia Lisboa1,2 (AUTHOR), Silva, Jaqueline Soares3 (AUTHOR), Samary, Cynthia dos Santos1,2 (AUTHOR), Vieira, Juliana Borges1,2 (AUTHOR), Cruz, Fernanda1,2 (AUTHOR), Rocha, Nazareth de Novaes1,2,4 (AUTHOR), Zapata‐Sudo, Gisele3 (AUTHOR), Rocco, Patricia Rieken Macedo1,2 (AUTHOR), Silva, Pedro Leme1,2 (AUTHOR) pedro.leme@gmail.com, de Mendonça, Lucas5,6 (AUTHOR), da Silva, Jaqueline Soares7 (AUTHOR), Zapata-Sudo, Gisele7 (AUTHOR)
Zdroj: British Journal of Pharmacology. Dec2019, Vol. 176 Issue 23, p4462-4473. 12p. 1 Diagram, 1 Chart, 8 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje